Clinical Assessment of Preventive Strategies for Chemotherapy Induced Nausea Vomiting in Cancer Patients at a Tertiary Care Teaching Hospital: A Prospective Study

This is Prospective Study, where we include patients of cancer diagnosis and undergoing chemotherapy as treatment with histological/pathological confirmation and experiencing chemotherapy-induced nausea and vomiting and exclude cancer patient who are not undergoing any chemotherapy treatment but are taking other standard treatment. In this study we aim to assess the anti-emetics used to prevent chemotherapy-induced nausea and vomiting and factors associated with increased risk of chemotherapy induced nausea and vomiting. We also aim to determine the impact of chemotherapy-induced nausea and vomiting (CINV) on the quality of life of cancer patients and to evaluate the effectiveness of clinical pharmacist–led interventions, including patient information leaflets, educational videos, mobile applications, and individualized counselling, in improving patient quality of life.